Evidence map›Paper›PMID 40386901›Full record

ArticleThe Cochrane database of systematic reviews2025

Perioperative immunotherapy strategies for resectable non-small cell lung cancer.

Corynne Marchal, Guillaume Eberst, François Calais, Virginie Westeel, Reem Malouf

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Cochrane database of systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Corynne MarchalMarie & Louis Pasteur University, Besançon, France.
Guillaume EberstDepartment of Chest Diseases and Thoracic Oncology, University Hospital of Besançon, Besançon, France.
François CalaisHealth Sciences University Library, Marie & Louis Pasteur University, Besançon, France.
Virginie WesteelDepartment of Chest Diseases and Thoracic Oncology, University Hospital of Besançon, Besançon, France.
Reem MaloufBig Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis is a protocol for a Cochrane Review (intervention). The objectives are as follows: To compare, via a network meta-analysis, the effectiveness and safety of different immunotherapy agents that are administered in a perioperative setting to people with resectable non small-cell lung cancer To perform indirect comparisons in order to generate a clinically meaningful hierarchy of perioperative strategies of immunotherapy administration for overall survival in operable people with resectable non small-cell lung cancer.

Indexed as

Antineoplastic Agents, ImmunologicalCarcinoma, Non-Small-Cell LungImmune Checkpoint InhibitorsImmunotherapyLung NeoplasmsPerioperative CareHumansNetwork Meta-Analysis as TopicNivolumabRandomized Controlled Trials as TopicAntineoplastic Agents, ImmunologicalImmune Checkpoint InhibitorsNivolumab

Identifiers

PMID40386901
PMCPMC12086965

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.